Filing Details
- Accession Number:
- 0000914062-13-000188
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-05-30 11:19:24
- Reporting Period:
- 2013-05-28
- Filing Date:
- 2013-05-30
- Accepted Time:
- 2013-05-30 11:19:24
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1133416 | Galectin Therapeutics Inc | GALT | Pharmaceutical Preparations (2834) | 043562325 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1522478 | D Kevin Freeman | C/O Galectin Therapeutics Inc. 4960 Peachtree Industrial Blvd, Ste 240 Norcross GA 30071 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2013-05-28 | 1,000 | $4.21 | 6,500 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- Reflects weighted average price. Range of prices were between $4.18 and $4.255. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.